Covaxin shows 78% efficacy in mild to severe Covid-19 cases: Bharat Biotech
3 years, 8 months ago

Covaxin shows 78% efficacy in mild to severe Covid-19 cases: Bharat Biotech

India Today  

Bharat Biotech on Wednesday announced results of its second interim analysis for Covaxin and said the vaccine has demonstrated an overall interim clinical efficacy of 78 per cent against mild, moderate and severe Covid-19. Apart from this, the result showed that Covaxin's efficacy against asymptomatic Covid-19 cases was 70 per cent, suggesting decreased transmission of the virus in recipients of the vaccine, Bharat Biotech said. Covaxin is now a global innovator vaccine derived from R&D in India," Bharat Biotech Chairman and Managing Director Krishna Ella said. ALSO WATCH | Bharat Biotech's Covaxin shows 78 per cent efficacy in phase-3 interim analysis

History of this topic

ICMR got ₹172 cr. from Bharat Biotech for Covaxin: Nadda
4 months, 3 weeks ago
The right way to counter a poor Covaxin safety study
4 months, 3 weeks ago
BHU’s Covaxin safety study riddled with major limitations
6 months, 4 weeks ago
1 in 3 Covaxin takers reported adverse events, BHU study claims
7 months, 1 week ago
BHU study: Over 30 per cent of Covaxin recipients report adverse events
7 months, 1 week ago
After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago
‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago
AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago
Covishield more effective than Covaxin: Study
9 months, 2 weeks ago
What study on Covishield versus Covaxin vaccine reveals
9 months, 2 weeks ago
With State prod, India can be world leader in vaccines
10 months, 4 weeks ago
New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago
COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago
A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago
India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 6 months ago
At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases
1 year, 7 months ago
India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago
Studies show XBB.1.16 is not clinically more severe
1 year, 8 months ago
India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago
India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 9 months ago
COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago
India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago
What is nasal vaccine - iNCOVACC? All you need to know
1 year, 10 months ago
Centre rolls out first nasal Covid vaccine as booster
1 year, 10 months ago
Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
1 year, 10 months ago
India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 10 months ago
COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago
COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 10 months ago
Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
1 year, 11 months ago
First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago
Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago
COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
1 year, 11 months ago
No second Covid-19 booster dose required: Report
1 year, 11 months ago
Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
1 year, 11 months ago
Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago
Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
1 year, 11 months ago
Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago
Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
1 year, 11 months ago
Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster
1 year, 11 months ago
Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
1 year, 11 months ago
Nasal vaccines to roll out in private hospitals soon
2 years ago
Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know
2 years ago
Bharat Biotech’s nasal vaccine to be available as booster dose
2 years ago
COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago
Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years ago
SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago
Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago
More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine
2 years ago
Bharat Biotech misstated Covaxin trial data
2 years ago

Discover Related